Projekt
Oceanic AF
Abgeschlossen - Rekrutierung – beendet · 2023 bis 2024
Rickli Hans, Fink Karin, Vetsch Susanne
Art
Reichweite
Bereiche
Status
Start
Ende
Finanzierungsart
Phase
Kurzbeschreibung/Zielsetzung
A multicenter, international, randomized, active comparator-controlled, double-blind, doubledummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) with apixaban for the prevention of stroke or systemic embolism in male and female participants aged 18 years and older with atrial fibrillation at risk for stroke